# US 2019/0172549 A1 · Systems and methods for analysis and interpretation of nucliec acid sequence data

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2019/0172549 A1
- Document ID: US20190172549A1
- Status: Published application
- Kind: A1
- Application number: 16/211,609
- Filed: 2018-12-06
- Published: 2019-06-06
- Earliest claimed: 2011-10-11
- Assignees: Life Technologies Corporation
- Applicants: Life Technologies Corporation
- Inventors: Brijesh KRISHNASWAMI; Yuandan LOU; Asim SIDDIQUI; Heinz BREU; Amitabh SHUKLA; Karl KUHLMANN
- Web page: https://patentgrep.com/patent/US20190172549A1

## CPC

- G16B 20/20: Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
- G06F 16/9038: Presentation of query results
- G16B 20/00: ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B 50/00: ICT programming tools or database systems specially adapted for bioinformatics
- G16B 50/10: Ontologies; Annotations
- G16B 20/10: Ploidy or copy number detection
- G16B: BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G06F: ELECTRIC DIGITAL DATA PROCESSING (computer systems based on specific computational models G06N)

## Abstract

Systems and method for annotating variants within a genome can call variants from reads or receive called variants directly and associate the called variants with functional annotations and interpretive annotations. A summary report of the called variants, the associated functional annotations, and the associated interpretive annotations can be generated.

## Claims

### Claim 1

A system, comprising:
a first data store configured to store genetic sequence information comprising called variants;
a second data store configured to store sequence annotation data; and
a processor communicatively connected with the first data store and the second data store, the processor configured to execute machine-readable instructions, which, when executed by the processor, cause the system to:
receive the called variants from the first data store,
receive functional type annotations from the second data store, wherein the functional type annotations include an indication of a change in an amino acid sequence, an indication of a change in an expression level of a protein and an indication of a change in a splicing of a transcript,
receive interpretive type annotations from the second data store,
normalize genomic coordinates of the functional type annotations and the interpretive type annotations to form normalized genomic coordinates for the functional type annotations and the interpretive type annotations,
assign positions to the called variants in accordance with the normalized genomic coordinates,
associate functional type annotations with the called variants based on the normalized genomic coordinates,
update the called variants in the first data store with the associated functional type annotations,
associate interpretive type annotations with the called variants based on the normalized genomic coordinates,
update the called variants in the first data store with the associated interpretive type annotations, and
generate a report of the called variants, the functional annotations, and the interpretive annotations.

### Claim 2 (depends on 1)

The system of claim 1, wherein the first data store includes an indexed database table of the called variants.

### Claim 3 (depends on 1)

The system of claim 1, wherein the functional type annotation includes a listing of transcripts impacted by the called variant.

### Claim 4 (depends on 3)

The system of claim 3, wherein the functional type annotation includes a protein function impact score for the called variant.

### Claim 5 (depends on 4)

The system of claim 4, wherein the functional type annotation includes base information for codons associated with the called variant.

### Claim 6 (depends on 1)

The system of claim 1, wherein the interpretive type annotation includes an association of the called variant with a disease, a correlation between the called variant and a response to a treatment, metabolic pathways impacted by the called variant, a biological signaling pathway impacted by the called variant, a regulation pathway impacted by the called variant or a match to a list of annotated variants.

### Claim 7 (depends on 1)

The system of claim 1, wherein the interpretive type annotation includes a metabolic pathway impacted by the called variant, a biological signaling pathway impacted by the called variant or a regulation pathway impacted by the called variant.

### Claim 8 (depends on 1)

The system of claim 1, wherein the processor is further configured to group the called variants that fall within blocks of overlapping transcripts together into a gene block and to annotate the called variants of the gene block at the same time.

### Claim 9 (depends on 1)

The system of claim 1, wherein the processor is further configured to:
select a set of variant report filter conditions,
query the first data store based on the set of variant filter conditions, and
provide results of the query for the report.

### Claim 10 (depends on 1)

The system of claim 1, wherein the processor is further configured to:
receive annotations information having an original format from an external annotations source;
convert the annotations information from the original format to a format compatible with a database structure of the second data store, and
store the converted annotations information to a database in the second data store.

### Claim 11

A method, comprising:
receiving called variants from a first data store configured to store genetic sequence information comprising the called variants;
receiving functional type annotations from a second data store, wherein the functional type annotations include an indication of a change in an amino acid sequence, an indication of a change in an expression level of a protein and an indication of a change in a splicing of a transcript;
receiving interpretive type annotations from the second data store;
normalizing genomic coordinates of the functional type annotations and the interpretive type annotations to form normalized genomic coordinates for the functional type annotations and the interpretive type annotations;
assigning positions to the called variants in accordance with the normalized genomic coordinates;
associating the functional type annotations with the called variants based on the normalized genomic coordinates;
updating the called variants in the first data store with the associated functional type annotations;
associating interpretive type annotations with the called variants based on the normalized genomic coordinates;
updating the called variants in the first data store with the associated interpretive type annotations; and
generating a report of the called variants, the functional annotations, and the interpretive annotations.

### Claim 12 (depends on 11)

The method of claim 11, further including:
selecting a set of variant report filter conditions;
querying the first data store based on the set of variant report filter conditions; and
providing results of the query for the report.

### Claim 13 (depends on 11)

The method of claim 11, wherein the functional-type annotation includes a listing of transcripts impacted by the called variant.

### Claim 14 (depends on 11)

The method of claim 11, wherein the functional-type annotation includes a protein function impact score for the called variant.

### Claim 15 (depends on 14)

The method of claim 14, wherein the functional-type annotation includes base information for codons associated with the called variant.

### Claim 16 (depends on 11)

The method of claim 11, wherein the interpretive type annotation includes an association of the called variant with a disease, a correlation between the called variant and a response to a treatment, metabolic pathways impacted by the called variant, a biological signaling pathway impacted by the called variant, a regulation pathway impacted by the called variant or a match to a list of annotated variants.

### Claim 17 (depends on 11)

The method of claim 11, wherein the interpretive type annotation includes a metabolic pathways impacted by the called variant, a biological signaling pathway impacted by the called variant or a regulation pathway impacted by the called variant.

### Claim 18 (depends on 11)

The method of claim 11 further comprising grouping the called variants that fall within blocks of overlapping transcripts together into a gene block and annotating the called variants of the gene block at the same time.

### Claim 19 (depends on 11)

The method of claim 11, further comprising:
receiving annotations information having an original format from an external annotations source;
converting the annotations information from the original format to a format compatible with a database structure of the second data store; and
storing the converted annotations information to a database in the second data store.

### Claim 20 (depends on 11)

The method of claim 11, wherein the first data store includes an indexed database table of the called variants.
